These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 29308554)

  • 1. Dynamics of Distribution of Capillaries with Matrix Metalloproteinase-2 and Its Tissue Inhibitor in Rat Brain during Development of Experimental Hypertension.
    Chertok VM; Chertok AG; Zakharchuk NV; Nevzorova VA
    Bull Exp Biol Med; 2018 Jan; 164(3):397-401. PubMed ID: 29308554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension.
    Ceron CS; Rizzi E; Guimaraes DA; Martins-Oliveira A; Cau SB; Ramos J; Gerlach RF; Tanus-Santos JE
    Matrix Biol; 2012 May; 31(4):261-70. PubMed ID: 22342460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
    Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
    Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
    Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats.
    Castro MM; Rizzi E; Figueiredo-Lopes L; Fernandes K; Bendhack LM; Pitol DL; Gerlach RF; Tanus-Santos JE
    Atherosclerosis; 2008 Jun; 198(2):320-31. PubMed ID: 18054360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy.
    Rizzi E; Ceron CS; Guimaraes DA; Prado CM; Rossi MA; Gerlach RF; Tanus-Santos JE
    Exp Mol Pathol; 2013 Feb; 94(1):1-9. PubMed ID: 23073243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin reduces myocardial fibrosis in a rat model with post-myocardial infarction heart failure by increasing the matrix metalloproteinase-2/tissue matrix metalloproteinase inhibitor-2 ratio.
    An Z; Yang G; He YQ; Dong N; Ge LL; Li SM; Zhang WQ
    Chin Med J (Engl); 2013; 126(11):2149-56. PubMed ID: 23769575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of TIMP-1 and TIMP-2 in the progression of cerebral aneurysms.
    Aoki T; Kataoka H; Moriwaki T; Nozaki K; Hashimoto N
    Stroke; 2007 Aug; 38(8):2337-45. PubMed ID: 17569872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
    Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
    Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of mRNAs encoding MMP-9 and MMP-2, and their inhibitors TIMP-1 and TIMP-2 by androgens in the rat ventral prostate.
    Limaye AM; Desai KV; Chavalmane AK; Kondaiah P
    Mol Cell Endocrinol; 2008 Nov; 294(1-2):10-8. PubMed ID: 18675881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension.
    Castro MM; Rizzi E; Rodrigues GJ; Ceron CS; Bendhack LM; Gerlach RF; Tanus-Santos JE
    Free Radic Biol Med; 2009 May; 46(9):1298-307. PubMed ID: 19248829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tanshinone II-A attenuates cardiac fibrosis and modulates collagen metabolism in rats with renovascular hypertension.
    Fang J; Xu SW; Wang P; Tang FT; Zhou SG; Gao J; Chen JW; Huang HQ; Liu PQ
    Phytomedicine; 2010 Dec; 18(1):58-64. PubMed ID: 20638255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant relation of tissue inhibitor of matrix metalloproteinase-2 and its combination with matrix metalloproteinase-2 to survival of patients with cancer of uterine cervix.
    Wang PH; Ko JL; Yang SF; Tsai HT; Tee YT; Han CP; Lin LY; Chen SC; Shih YT
    Reprod Sci; 2011 Aug; 18(8):798-808. PubMed ID: 21422052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.
    Berceli SA; Jiang Z; Klingman NV; Pfahnl CL; Abouhamze ZS; Frase CD; Schultz GS; Ozaki CK
    J Vasc Surg; 2004 May; 39(5):1084-90. PubMed ID: 15111865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats.
    Martinez ML; Castro MM; Rizzi E; Fernandes K; Demacq C; Bendhack LM; Gerlach RF; Tanus-Santos JE
    Eur J Pharmacol; 2008 Sep; 591(1-3):224-30. PubMed ID: 18634778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of tissue inhibitor of metalloproteases-1 (TIMP-1) and procollagen-N-peptidase in hypertension-induced renal damage.
    Hultström M; Leh S; Skogstrand T; Iversen BM
    Nephrol Dial Transplant; 2008 Mar; 23(3):896-903. PubMed ID: 17977875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and localization of matrix metalloproteinases (MMP-2, -7, -9) and their tissue inhibitors (TIMP-2, -3) in the chicken oviduct during pause in laying induced by tamoxifen.
    Leśniak-Walentyn A; Hrabia A
    Theriogenology; 2017 Jan; 88():50-60. PubMed ID: 27865412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
    Wei QY; Wu YQ; Fan SQ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.